Spinocerebellar Ataxia Type 3 Repeat Analysis
NY Approved
Test Overview
Clinical Utility
- Molecular confirmation of a clinical diagnosis
- Identification of at-risk family members
- Assist with treatment/management decisions
- Recurrence risk assessment
Test Details
Genes
ATXN3
Conditions
- Spinocerebellar Ataxia type 3 (SCA3)
Lab Method
- PCR Fragment Analysis
Ordering Information
Resources
Test Documents
Billing
Targeted Variant Testing